Novo Integrated Sciences 주식 (OTC: NVOS)

에 대한 최신 뉴스 Novo Integrated Sciences (OTC:NVOS) 주식

Novo Integrated Sciences

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

NOVO INTEGRATED SCIENCES by Novo Integrated Sciences, Inc.

Novo Integrated Sciences Inc

The investment consists of the purchase of 12.5 million shares of Verde's Class A common stock at a purchase price of $4.00 per share. Closing of the investment is anticipated to occur during Q1 2025, subject to satisfaction of customary closing conditions. Upon closing, the investment would represent the second investment by Cottonmouth in Verde over the past two years, for a total investment of $70 million, making Cottonmouth the second largest shareholder of Verde.&nbsp;

News

Financing

Commodities

Markets

General

FANG

VGAS

Verde Clean Fuels Entered Into A Stock Purchase Agreement With Cottonmouth Ventures, A Wholly-Owned Subsidiary Of Diamondback Energy, For A $50M Equity Investment

In a bid to attract budget-savvy travelers, Frontier Airlines by Frontier Group Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) has announced the launch of its &#8220;GoWild!&#8221; pass, offering unlimited flights for a year at an introductory price of $299. This offer, which targets spontaneous adventurers, is available to the first 5,000 customers who sign up before the pre-sale ends on December 18.
What Happened: Frontier Airlines is launching a new offer aimed at budget-conscious travelers. The airline&#8217;s &#8220;GoWild!&#8221; pass, priced at $299 annually, provides unlimited flights for a limited time, CNBC <a href="https://www.cnbc.com/2024/12/18/frontier-airlines-all-you-can-fly-pass.html">reported</a> on Thursday 
The &#8220;GoWild!&#8221; pass is designed for spontaneous travelers and those seeking endless adventures, according to Bobby Schroeter, Chief Commercial Officer of Frontier Airlines. The offer is limited to the first 5,000 customers who sign up before the pre-sale ends on Dec. 18 at 11:59 p.m. MST. After this period, the price will rise to $499.
See Also: <a href="https://www.benzinga.com/tech/24/12/42525257/analyst-hikes-teslas-price-target-to-515-musk-expresses-hope-for-stock-to-touch-69042?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Hopes TSLA Stock Will Reach $690 As Analysts Raise Price Target Despite Technical Indicators Flashing Warning Signals</a>
Eligibility for the pass requires users to be at least 18 years old, U.S. residents,&nbsp;and members of Frontier Miles,&nbsp;the airline&#8217;s loyalty program. New customers will be enrolled automatically upon purchase. Pass holders can book flights for a penny, but must cover taxes and fees.
Restrictions include no seat reservations and no carry-on or checked baggage. Domestic flights can be booked a day before departure, while international flights require a 10-day advance booking. The pass is valid from May 1, 2025, to April 30, 2026, excluding holiday and peak travel dates.
Why It Matters: The introduction of the &#8220;GoWild!&#8221; pass by Frontier Airlines comes amid a growing trend among budget airlines to offer unlimited flight passes. In August, European budget airline Wizz Air Holdings launched a similar initiative <a href="https://www.benzinga.com/news/24/08/40387905/this-least-punctual-airline-is-now-offering-a-550-all-you-can-fly-annual-pass-with-unlimited-flights">with a $550 annual pass</a>, allowing unlimited flights to international destinations. 
This pass, available initially at a discounted rate, aimed to attract more customers despite the airline&#8217;s reputation for punctuality issues. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42545829/mark-cuban-expresses-sympathy-for-hawk-tuah-girl-amid-meme-coin-controversy-wasnt-something-she-fully-understood?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Expresses Sympathy For &#8216;Hawk Tuah&#8217; Girl Amid Meme Coin Controversy: &#8216;Wasn&#8217;t Something She Fully Understood&#8217;</a></li>
</ul>
Image via Shutterstock

Travel

ULCC

This Budget US Airline Is Offering A 'GoWild' Pass: Catch Unlimited Flights For A Year At $299

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

Analyst Ratings

PATH

Needham Reiterates Hold on UiPathto Hold

Jefferies analyst Joseph Gallo upgrades SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) from Hold to Buy and raises the price target from $27 to $30.

Upgrades

Price Target

Jefferies Upgrades SentinelOne to Buy, Raises Price Target to $30

BP1001-A downregulates growth factor receptor-bound protein 2 (Grb2) expression to increase insulin sensitivity and helps lower blood glucose level in Type 2 diabetes patients. Scientific evidence suggeststhat by downregulating Grb2 expression, BP1001-A&nbsp;could help lower blood glucose level by affecting insulin signaling. Bio-Path conducted preclinical studies that confirmed the effectiveness of BP1001-A in affecting insulin signaling and its potential efficacy as a therapeutic treatment for obese patients who have Type 2 diabetes.&nbsp;&nbsp; The study results showed:
<ul>
<li>BP1001-A reduced Grb2 protein expression in myoblast cells</li>
<li>BP1001-A increased the levels of phosphorylated AKT and phosphorylated FOXO-1 in myoblast and hepatoma cells in the presence of insulin</li>
</ul>
These initial data confirmed that by downregulating Grb2 expression, BP1001-A could enhance insulin-induced metabolic events by affecting the insulin/phosphoinositol-3 kinase (PI3K)/AKT pathway and increase insulin sensitivity.&nbsp;

Biotech

Health Care

BPTH

Bio-Path Reported That Results From Preclinical Studies Of BP1001-A For Obesity Demonstrated Enhanced Insulin Sensitivity, Confirming BP1001-A As A Potential Treatment For Obesity And Related Metabolic Diseases In Type 2 Diabetes Patients

WIIM

Bio-Path Holdings shares are trading higher after the company announced preclinical testing of BP1001-A as a potential treatment for obesity in Type 2 diabetes patients by enhancing insulin sensitivity.

MNMD

MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024

Contracts

VRAR

The Glimpse Group shares are trading higher after its subsidiary, Brightline Interactive, announced a six-figure contract with the U.S. Navy for an immersive simulator.

ACET

Adicet Bio Says First Patient Dosed In The Phase 1 Clinical Trial Evaluating ADI-270 In Patients With Metastatic/Advanced ccRCC

The Glimpse Group's Subsidiary Company Brightline Interactive Has Entered Into An Initial Six Figure Dollar Contract With The U.S. Navy For An Immersive Simulator, To Be Delivered In The First Half Of 2025

Jefferies analyst Michael Yee downgrades ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) from Buy to Hold and lowers the price target from $12 to $2.

Downgrades

ALXO

Jefferies Downgrades ALX Oncology Holdings to Hold, Lowers Price Target to $2

Fiscal 2025 Expectations
•Organic ASV is expected to grow in the range of $90 million to $140 million during fiscal 2025.
•GAAP revenues are expected to be in the range of $2,285 million to $2,305 million.
•GAAP operating margin is expected to be in the range of 32.5% to 33.5%.
•Adjusted operating margin is expected to be in the range of 36.0% to 37.0%.
•FactSet's annual effective tax rate is expected to be in the range of 17% to 18%.
•GAAP diluted EPS is expected to be in the range of $15.10 to $15.70.
•Adjusted diluted EPS is expected to be in the range of $16.80 to $17.40.

Earnings

Guidance

FactSet Reaffirms FY25 Guidance: Sees Revenues Of $2.285B - $2.305B Vs. $2.301B Est., And Adjusted EPS Of $16.80 - $17.40 Vs. $17.17 Est.

HC Wainwright &amp; Co. analyst Sean Lee reiterates Verastem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) with a Buy and maintains $7 price target.

VSTM

HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $7 Price Target

LASE

Laser Photonics Receives Dual Order From Oil Refiner Phillips 66 For CleanTech And MarkStar Laser Systems; No Terms Disclosed

In addition to the Fast Track designation announced today for Waldenstrom's macroglobulinemia, NX-5948 previously received Fast Track designation in January 2024 for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) after at least two lines of therapy, including a BTK inhibitor and a B-cell lymphoma 2 (BCL2) inhibitor.

NRIX

Nurix Says FDA Granted Fast Track Designation For NX-5948 For Treatment Of Adult Patients With Relapsed Or Refractory Waldenstrom's Macroglobulinemia After At Least Two Lines Of Therapy

Jefferies analyst Samad Samana upgrades Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) from Hold to Buy and raises the price target from $85 to $100.

Jefferies Upgrades Zoom Communications to Buy, Raises Price Target to $100

Management

LXEO

Lexeo Therapeutics Appoints Dr. Kyle Rasbach As Chief Financial Officer, Effective Immediately.

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Uranium Royalty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UROY#NASDAQ">UROY</a>) with a Buy and maintains $7.7 price target.

UROY

HC Wainwright & Co. Reiterates Buy on Uranium Royalty, Maintains $7.7 Price Target

REGN7508 (catalytic domain) is designed to maximize anticoagulant activity while minimizing bleeding risk, and REGN9933 (A2 domain) is designed to provide an additional option for patients with the highest bleeding risk who would otherwise not be candidates for currently available anticoagulants.&nbsp;
Per the Phase 2 results, there was an antithrombotic effect for each antibody, and no clinically relevant bleeding was observed in any treatment arm.

REGN

Regeneron Reports Phase 2 Results For Two Novel Monoclonal Antibodies Targeting Distinct Domains Of Factor XI; Says There Was Antithrombotic Effect For Each Antibody; Phase 3 Program To Be Initiated In 2025

Fiscal 2025 Financial Outlook The Company updated its full year financial outlook for fiscal 2025 which now includes Chuy's operating results, but excludes approximately $47 million, pre-tax, of expected transaction and integration related costs associated with the acquisition. The Company will provide additional details during its investor conference call scheduled for this morning at 8:30 am ET.
<ul>
<li>Total sales of approximately $12.1 billion</li>
<li>Same-restaurant sales growth of approximately 1.5%&#x2A;</li>
<li>New restaurant openings of 50 to 55</li>
<li>Total capital spending of approximately $650 million</li>
<li>Total inflation of approximately 2.5%</li>
<li>An effective tax rate of approximately 12.5%</li>
<li>Diluted net earnings per share from continuing operations of $9.40 to $9.60, excluding approximately $47 million, pre-tax, of Chuy's transaction and integration related costs&#x2A;&#x2A;</li>
<li>Approximately 118 million weighted average diluted shares outstanding</li>
</ul>

Restaurants

Darden Restaurants Expects 2025 Sales Of Approximately $12.1B Vs. Consensus Of $12.084B

Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more

Novo Integrated Sciences files to resell 3.5M shares by holders

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!



Moving stocks this morning are earnings reports, new agreements, public offerings and more.



We have all of that news ready below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Pineapple Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/pegy-stock-quote/">PEGY</a>) stock is rocketing more than 83% after <a href="https://www.nasdaq.com/press-release/pineapple-energy-formalizes-agreement-conduit-capital-services-and-pursue-working">announcing a new collaboration</a>.</li>



<li>Anew Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/">WENA</a>) shares are soaring over 67% on <a href="https://www.nasdaq.com/press-release/anew-medical-advance-patented-klotho-gene-therapy-neurodegenerative-disorder">therapy advancement plans</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is surging more than 47% without any clear news this morning.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) shares are gaining over 23% on <a href="https://www.nasdaq.com/press-release/60-degrees-pharma-announces-irb-approval-clinical-study-tafenoquine-treatment">approval of a clinical study</a>.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) stock is rising more than 23% with heavy pre-market trading.</li>



<li>Mainz Biomed (NASDAQ:<a href="https://investorplace.com/stock-quotes/mynz-stock-quote/">MYNZ</a>) shares are climbing over 17% after <a href="https://www.nasdaq.com/press-release/mainz-biomed-announces-submission-fda-breakthrough-device-designation-its-next">submitting a test</a> for breakthrough designation.</li>



<li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is jumping more than 17% despite a lack of news.</li>



<li>Interactive Strength (NASDAQ:<a href="https://investorplace.com/stock-quotes/trnr-stock-quote/">TRNR</a>) shares are heading over 13% higher on a <a href="https://www.nasdaq.com/press-release/interactive-strength-inc-nasdaq-trnr-secures-exclusive-distribution-clmbr-fast">distribution agreement and order</a>.</li>



<li>YY Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/yygh-stock-quote/">YYGH</a>) stock is increasing more than 12% without any obvious news.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) shares are up over 12% on <a href="https://www.nasdaq.com/press-release/srivaru-svmh-deploys-advanced-ai-platform-manage-lead-generation-platform-prana-20">artificial intelligence (AI) platform deployment</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Indivior (NASDAQ:<a href="https://investorplace.com/stock-quotes/indv-stock-quote/">INDV</a>) stock is plummeting more than 36% alongside a <a href="https://www.nasdaq.com/press-release/indivior-provides-business-update-conference-call-8-00-am-us-edt-2024-07-09">worrying business update</a>.</li>



<li>Helen Of Troy (NASDAQ:<a href="https://investorplace.com/stock-quotes/hele-stock-quote/">HELE</a>) shares are diving over 23% with the <a href="https://www.nasdaq.com/press-release/helen-troy-limited-reports-first-quarter-fiscal-2025-results-2024-07-09">release of its latest earnings report</a>.</li>



<li>Shapeways (NASDAQ:<a href="https://investorplace.com/stock-quotes/shpw-stock-quote/">SHPW</a>) stock is tumbling more than 19% <a href="https://investorplace.com/2024/07/why-is-shapeways-shpw-stock-up-84-today/">after a rally yesterday</a>.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are taking an over 17% beating on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318441400&amp;type=PDF&amp;symbol=NVOS&amp;cdn=2b225bb2253ffcb31b2332a6ef2a7e6d&amp;companyName=Novo+Integrated+Sciences+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-07-08">proposed public offering</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) stock is sliding more than 14% with strong pre-market trading.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are decreasing 13% on a <a href="https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-proposed-public-210000234.html">proposed public offering</a>.</li>



<li>Above Food Ingredients (NASDAQ:<a href="https://investorplace.com/stock-quotes/abve-stock-quote/">ABVE</a>) stock is falling over 11% without any apparent news.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are retreating 11% on Tuesday morning.</li>



<li>Helios Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/hlio-stock-quote/">HLIO</a>) stock is slipping more than 10% on <a href="https://www.nasdaq.com/press-release/helios-technologies-announces-leadership-team-update-2024-07-08">changes to its leadership team</a>.</li>



<li>Inuvo (NYSEMKT:<a href="https://investorplace.com/stock-quotes/inuv-stock-quote/">INUV</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Novo Integrated Sciences (NVOS) just unveiled an announcement. Novo Integrated Sciences, Inc. has announced the initiation of funds disbursement fr...

Novo Integrated Sciences Announces Major Funds Disbursement

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Friday as we check out all of the latest stories affecting shares on the last day of trading this week!



Moving stocks this morning are a Maui fire settlement report, a reverse stock split notice, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is rocketing more than 68% with heavy trading after announcing <a href="https://www.nasdaq.com/press-release/presentation-times-and-schedule-participating-companies-now-posted-conference-website">a presentation yesterday</a>.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) shares are soaring over 37% alongside strong early morning trading.</li>



<li>Hawaiian Electric Industries (NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>) stock is surging more than 37% on reports it included in the <a href="https://finance.yahoo.com/news/hawaiian-electric-among-firms-4-212211492.html">Maui fire settlement</a>.</li>



<li>Power REIT (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pw-stock-quote/">PW</a>) shares are increasing over 23% without any apparent news.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is gaining more than 23% with strong pre-market trading.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are rising over 22% on a <a href="https://www.businesswire.com/news/home/20240718621664/en/Novo-Integrated-Sciences-Receives-Commencement-of-Disbursement-Notice-for-SBLC-Leasing-and-Monetizing-Program">disbursement funds notice</a>.</li>



<li>Unicycive Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/uncy-stock-quote/">UNCY</a>) stock is climbing more than 15% despite a lack of news this morning.</li>



<li>Talphera (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/">TLPH</a>) shares are heading over 13% higher without any clear news to report.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is jumping close to 13% on Friday morning.</li>



<li>Sobr Safe (NASDAQ:<a href="https://investorplace.com/stock-quotes/sobr-stock-quote/">SOBR</a>) shares are up more than 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock is diving over 19% after <a href="https://www.prnewswire.com/news-releases/nauticus-robotics-announces-transformative-1-for-36-reverse-stock-split-302201004.html">announcing a reverse stock split</a>.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) shares are tumbling more than 17% after <a href="https://finance.yahoo.com/news/sunpower-plunges-halting-solar-installs-180816388.html">halting some of its operations</a>.</li>



<li>WaveDancer (NASDAQ:<a href="https://investorplace.com/stock-quotes/wavd-stock-quote/">WAVD</a>) stock is taking a nearly 14% beating on Friday morning.</li>



<li>CrowdStrike (NASDAQ:<a href="https://investorplace.com/stock-quotes/crwd-stock-quote/">CRWD</a>) shares are sliding over 13% <a href="https://www.cnbc.com/2024/07/19/crowdstrike-suffers-major-outage-affecting-businesses-around-the-world.html">alongside outages and issues</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 11% <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">following clinical trial results yesterday</a>.</li>



<li>Scholastic (NASDAQ:<a href="https://investorplace.com/stock-quotes/schl-stock-quote/">SCHL</a>) shares are decreasing over 11% with its <a href="https://www.benzinga.com/news/earnings/24/07/39849856/scholastic-shares-fall-after-worse-than-expected-q4-results-details">fiscal Q4 earnings report</a>.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) stock is falling more than 10% after a major rally yesterday.</li>



<li>HighPeak Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/hpkew-stock-quote/">HPKEW</a>) shares are slipping over 10% this morning.</li>



<li>Super League Enterprise (NASDAQ:<a href="https://investorplace.com/stock-quotes/sle-stock-quote/">SLE</a>) stock is dipping almost 10% today.</li>



<li>CytoMed Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdtc-stock-quote/">GDTC</a>) shares are down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-19th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) just reported results for the third quarter of 2024.<ul><li>Novo Integrated Sciences reported earnings per share of -74 cents.</li><li>The company reported revenue of $3.15 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/07/nvos-stock-earnings-novo-integrated-sciences-for-q3-of-2024/">NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q3 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic as we dive into all of the biggest news traders need to know about on Monday morning!



Moving stocks this morning are an acquisition deal, a strategic alliance, earnings data and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tellurian (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tell-stock-quote/">TELL</a>) stock is rocketing more than 66% <a href="https://finance.yahoo.com/news/tellurian-acquired-woodside-approximately-900-222900949.html">due to a $900 million acquisition deal</a>.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) shares are soaring over 60% after Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) <a href="https://investorplace.com/2024/07/serv-stock-soars-as-nvidia-reveals-big-bet-on-serve-robotics/">revealed a stake in the company</a>.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) stock is surging more than 56% after <a href="https://www.nasdaq.com/press-release/castellum-inc-announces-strategic-alliance-k2-2024-07-22">announcing a strategic alliance</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares are rising over 40% alongside heavy pre-market trading.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is increasing more than 27% after <a href="https://www.nasdaq.com/press-release/richtech-robotics-celebrates-completion-installation-adam-ghost-kitchens-inside">adding ADAM to certain ghost kitchens</a>.</li>



<li>CISO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/ciso-stock-quote/">CISO</a>) shares are gaining over 24% after announcing <a href="https://www.nasdaq.com/press-release/ciso-global-announces-solution-mitigate-impact-crowdstrike-security-event-2024-07-19">a way to mitigate damage</a> from the CrowdStrike (NASDAQ:<a href="https://investorplace.com/stock-quotes/crwd-stock-quote/">CRWD</a>) issues last week.</li>



<li>Tellurian Inc. 8.25% Senior Notes due 2028 (NYSEMKT:<a href="https://investorplace.com/stock-quotes/telz-stock-quote/">TELZ</a>) are heading more than 21% higher this morning.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock is climbing over 18% without any clear news this morning.</li>



<li>Society Pass (NASDAQ:<a href="https://investorplace.com/stock-quotes/sopa-stock-quote/">SOPA</a>) shares are jumping more than 17% on Monday morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is up over 16% without any clear news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is plummeting more than 24% after a major rally on Friday.</li>



<li>Sentage (NASDAQ:<a href="https://investorplace.com/stock-quotes/sntg-stock-quote/">SNTG</a>) shares are diving over 14% on Monday morning.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) stock is tumbling close to 14% this morning.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are taking a nearly 14% beating after <a href="https://investorplace.com/earning-results/2024/07/nvos-stock-earnings-novo-integrated-sciences-for-q3-of-2024/">jumping Friday on earnings</a>.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is sliding over 13% on Monday morning.</li>



<li>Ryanair (NASDAQ:<a href="https://investorplace.com/stock-quotes/ryaay-stock-quote/">RYAAY</a>) shares are falling more than 13% alongside <a href="https://www.cnbc.com/2024/07/22/ryanair-q1-2024-results-shares-fall-on-lower-fares-fall-in-quarterly-profit.html">falling quarterly profit</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is dropping over 11% on Monday.</li>



<li>Stronghold Digital Mining (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdig-stock-quote/">SDIG</a>) shares are decreasing more than 11% this morning.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) stock is slipping over 10% on Monday morning.</li>



<li>PS International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) shares close out our pre-market stock movers down almost 10% on Monday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Novo Integrated Sciences GAAP EPS of -$0.74, revenue of $3.15M

The latest update is out from Novo Integrated Sciences ( ($NVOS) ). Novo Integrated Sciences and the Successor Receiver have terminated their $60 m...

Novo Integrated Sciences Ends $60M Gemstone Deal

Novo Integrated Sciences ( ($NVOS) ) has shared an update. Robert Mattacchione has announced his resignation as CEO of Novo Integrated Sciences, ef...

Novo Integrated Sciences CEO Resigns Amid Annual Meeting Plans

ABVE

AFAR

AIRE

BNOX

BSET

BSVN

BYRN

CCEL

CISO

CRWD

EDUC

EPAC

ERIC

ETWO

EVGR

FAST

FNGR

GDST

GDTC

GNLN

HELE

HIFS

HLIO

HPKEW

INDV

INUV

KITT

KRUS

LEDS

LEXX

MANU

MYNZ

NCPL

NTIC

NUZE

NVDA

NVOS

PCYO

PEGY

PRTG

PSIG

PSMT

QLGN

RYAAY

SCHL

SDIG

SERV

SHPW

SLRX

SNOA

SNTG

SOBR

SOPA

SPWR

SVMH

SXTP

TCBP

TELL

TELZ

TLPH

TNXP

TPHS

TRNR

UNCY

UPXI

VIST

VOXX

WAVD

WDFC

WENA

XAIR

XCUR

YYGH

ZAPP

Press Releases

Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results

Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products

Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results

Comments

Novo Integrated Sciences

뉴스

에 대한 최신 뉴스 Novo Integrated Sciences (OTC:NVOS) 주식

뉴스

파트너 / 기고자

벤징가 글로벌